GI Dysfunction Can Impair Effects of Duodopa/Duopa
Gastrointestinal (GI) dysmotility, or lack of movement, can impair the absorption and delay the effects of levodopa-based medication in people with Parkinson’s disease, a study reports. Notably, the study describes the cases of two Parkinson’s patients who stopped responding to levodopa/carbidopa intestinal gel — available under the brand name…